FDA Inspection 1306310 — SGS Institut Fresenius GmbH
The FDA completed an inspection of SGS Institut Fresenius GmbH on Feb 2, 2026 in Taunusstein. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 2, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Taunusstein (Germany)